ATE4956T1 - Nitroglycerin enthaltendes praeparat und moeglicherweise andere medikamente und deren herstellung. - Google Patents

Nitroglycerin enthaltendes praeparat und moeglicherweise andere medikamente und deren herstellung.

Info

Publication number
ATE4956T1
ATE4956T1 AT80303912T AT80303912T ATE4956T1 AT E4956 T1 ATE4956 T1 AT E4956T1 AT 80303912 T AT80303912 T AT 80303912T AT 80303912 T AT80303912 T AT 80303912T AT E4956 T1 ATE4956 T1 AT E4956T1
Authority
AT
Austria
Prior art keywords
preparation
nitroglycerine
medications
possibly
manufacture
Prior art date
Application number
AT80303912T
Other languages
English (en)
Inventor
Stewart Thomas Leslie
Alan Rhodes
Original Assignee
Mundipharma A.G.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mundipharma A.G. filed Critical Mundipharma A.G.
Application granted granted Critical
Publication of ATE4956T1 publication Critical patent/ATE4956T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT80303912T 1979-11-06 1980-11-04 Nitroglycerin enthaltendes praeparat und moeglicherweise andere medikamente und deren herstellung. ATE4956T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7938380 1979-11-06
EP80303912A EP0028526B1 (de) 1979-11-06 1980-11-04 Nitroglycerin enthaltendes Präparat und möglicherweise andere Medikamente und deren Herstellung

Publications (1)

Publication Number Publication Date
ATE4956T1 true ATE4956T1 (de) 1983-10-15

Family

ID=10508999

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80303912T ATE4956T1 (de) 1979-11-06 1980-11-04 Nitroglycerin enthaltendes praeparat und moeglicherweise andere medikamente und deren herstellung.

Country Status (6)

Country Link
US (2) US4322433A (de)
EP (1) EP0028526B1 (de)
AT (1) ATE4956T1 (de)
CA (1) CA1163561A (de)
DE (1) DE3065315D1 (de)
GB (1) GB2062465B (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1163561A (en) * 1979-11-06 1984-03-13 Cyril Boroda Preparation containing nitroglycerine and optionally other medicaments and preparation thereof
US4450175A (en) * 1982-09-23 1984-05-22 Warshaw Thelma G Method and compositions for treating acne
JPS59139315A (ja) * 1983-01-31 1984-08-10 Taisho Pharmaceut Co Ltd クリ−ム剤
DE3333639A1 (de) * 1983-09-17 1985-03-28 Dynamit Nobel Ag Zubereitung von nitroestern fuer die koronartherapie
US4764381A (en) * 1985-12-06 1988-08-16 Key Pharmaceuticals, Inc. Percutaneous penetration enhancer of oleic acid and 2-ethyl-1, 3-hexanediol
US5204339A (en) * 1986-01-31 1993-04-20 Whitby Research, Inc. Penetration enhancers for transdermal delivery of systemic agents
US5196410A (en) * 1986-10-31 1993-03-23 Pfizer Inc. Transdermal flux enhancing compositions
US4775529A (en) * 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
US4879308A (en) * 1987-08-11 1989-11-07 Lyphomed, Inc. Aqueous nitroglycerin injection and manufacturing process
US5002938A (en) * 1988-03-21 1991-03-26 Bristol-Myers Squibb Company Antifungal gel formulations
US5110809A (en) * 1988-03-21 1992-05-05 Bristol-Myers Squibb Company Antifungal gel formulations
US5183665A (en) * 1989-01-23 1993-02-02 Nitto Denko Corporation Composition for percutaneous administration and method for enhancing percutaneous absorption of a physiologically active ingredient empolying the same
US5091186A (en) * 1989-08-15 1992-02-25 Cygnus Therapeutic Systems Biphasic transdermal drug delivery device
US5262165A (en) * 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
US5240917A (en) * 1991-04-03 1993-08-31 Keimowitz Rudolph M Suppression of thromboxane levels by percutaneous administration of aspirin
US5679337A (en) * 1991-06-14 1997-10-21 Professional Pharmaceutical, Inc. Method and composition for topical treatment of Aphthous stomatitis histamine using phosphate as active ingredient
US5234690A (en) * 1991-08-23 1993-08-10 Cygnus Therapeutic Systems Transdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset
US5273756A (en) * 1991-08-23 1993-12-28 Cygnus Therapeutic Systems Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset
US6071896A (en) * 1992-06-16 2000-06-06 Gundersen Clinic, Ltd. Suppression of thromboxane levels by percutaneous administration of aspirin
US5268046A (en) * 1992-08-14 1993-12-07 Hercules Incorporated Surfactant stabilized nitroglycerin emulsion
US5698589A (en) * 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof
ES2199961T3 (es) * 1994-03-02 2004-03-01 Professional Pharmaceutical, Inc. Uso de una composicion que contiene fosfato de histamina para la obtencion de un medicamento para el tratamiento local de las inflamaciones o lesiones epiteliales.
EP0719145B1 (de) * 1994-05-27 2000-09-06 Cellegy Pharmaceuticals, Inc. Stickstoffoxyd abgebendes präparat zur behandlung von analen erkrankungen
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
US6036977A (en) * 1995-09-29 2000-03-14 L.A.M. Pharmaceutical Corp. Drug preparations for treating sexual dysfunction
US6007843A (en) 1995-09-29 1999-12-28 Lam Pharmaceuticals Corp. Sustained release delivery system
US5952006A (en) * 1995-09-29 1999-09-14 L.A.M. Pharmaceuticals, Llc Drug preparations for treating impotency
SE520811C2 (sv) * 1997-01-17 2003-08-26 Ponsus Ab Hudskyddspreparat innehållande lipofila och hydrofila komponenter, förfarande för framställning och användning därav
GB9711032D0 (en) * 1997-05-30 1997-07-23 Johnson Matthey Plc Compound as a stimulant for the central nervous system
WO1998058633A2 (en) 1997-06-23 1998-12-30 Queen's University At Kingston Microdose therapy of vascular conditions by no donors
DE19819012A1 (de) * 1998-04-29 1999-11-25 Dynamit Nobel Ag Feuersichere, nicht explosionsfähige, Nitroglycerin und wasserfreie Lactose enthaltende Feststoffmischungen
US7179483B2 (en) * 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
MXPA03007960A (es) 2001-03-06 2003-12-04 Cellegy Pharma Inc Compuestos y metodos para el tratamiento de desordenes urogenitales.
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
WO2003032944A1 (en) * 2001-10-12 2003-04-24 Aq+ Plc Anti-microbial composition comprising a metal ion chelating agent
US6863901B2 (en) * 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
US8450302B2 (en) * 2002-08-02 2013-05-28 Ab Science 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
US20050239852A1 (en) * 2002-08-02 2005-10-27 Ab Science 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
US7041286B2 (en) * 2003-07-23 2006-05-09 Nerenberg Arnold P Composition for mitigating a pernicious thrombotic event
PL1684750T3 (pl) * 2003-10-23 2010-10-29 Ab Science 2-Aminoarylooksazole jako inhibitory kinazy tyrozynowej
UA95071C2 (ru) * 2005-04-04 2011-07-11 Аб Сьянс Замещенные производные оксазола и их применение как ингибиторов тирозинкиназы
FR2892936A1 (fr) * 2005-11-10 2007-05-11 Galderma Res & Dev Composition pharmaceutique ou cosmetique, et procede de solubilisation mixte pour preparer la composition.
WO2008105920A1 (en) * 2007-02-28 2008-09-04 Collegium Pharmaceutical, Inc. Antihistamine combination
EP2363116A1 (de) 2008-06-25 2011-09-07 US Worldmeds LLC Lofexidin enthaltende Formulierungen mit verzögerter Freisetzung zur oralen Verabreichung
US20110092493A1 (en) * 2008-09-24 2011-04-21 Clark Levi Dose-controlled transdermal promethazine compositions and methods of use
JP5734313B2 (ja) 2010-01-12 2015-06-17 アーべー・シオンス チアゾールおよびオキサゾールキナーゼ阻害剤
US20120302577A1 (en) 2010-01-28 2012-11-29 Ab Science Treatment of gist with masitinib
BR112014001977A2 (pt) 2011-07-27 2017-02-21 Ab Science inibidores seletivos de proteína quinase
CN106414433A (zh) 2014-03-24 2017-02-15 Ab科学有限公司 作为脾酪氨酸激酶抑制剂的二氮杂螺烷酮取代的噁唑衍生物
ES2796276T3 (es) 2015-02-05 2020-11-26 Ab Science Compuestos con actividad antitumoral
EP3144307A1 (de) 2015-09-18 2017-03-22 AB Science Neue oxazol derivaten als syk kinasehemmer
CA3085013A1 (en) 2017-12-13 2019-06-20 Onquality Pharmaceuticals China Ltd. A method for preventing or treating egfr-inhibition associated diseases
TW201943428A (zh) 2018-04-16 2019-11-16 大陸商上海岸闊醫藥科技有限公司 預防或治療腫瘤療法副作用的方法
US12070440B2 (en) 2022-06-27 2024-08-27 Permeatus, Inc. Topical formulations of nitroglycerin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395215A (en) * 1964-10-15 1968-07-30 Colgate Palmolive Co Pressurized lotion composition
US3551554A (en) * 1968-08-16 1970-12-29 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active agents with dmso
US3609102A (en) * 1969-10-02 1971-09-28 Paris Cosmetics Inc Multicolored transparent polymer gel emollient bases, with oil-miscible dyes, for oil-soluble cosmetics, perfume and pharmaceuticals
US3789119A (en) * 1971-06-01 1974-01-29 Parke Davis & Co Stabilized molded sublingual nitroglycerin tablets
US4197318A (en) * 1974-07-08 1980-04-08 Johnson & Johnson Potentiated antimicrobial medicaments
US4112115A (en) * 1976-11-08 1978-09-05 Coghlan Charles C Therapy of leg muscle cramps
CA1163561A (en) * 1979-11-06 1984-03-13 Cyril Boroda Preparation containing nitroglycerine and optionally other medicaments and preparation thereof
JPS599539B2 (ja) * 1979-11-13 1984-03-03 日本化薬株式会社 ニトログリセリン水溶液及びその製造法

Also Published As

Publication number Publication date
EP0028526B1 (de) 1983-10-12
US4322433A (en) 1982-03-30
GB2062465A (en) 1981-05-28
GB2062465B (en) 1984-01-25
DE3065315D1 (en) 1983-11-17
CA1163561A (en) 1984-03-13
EP0028526A2 (de) 1981-05-13
US4654209A (en) 1987-03-31
EP0028526A3 (en) 1981-11-25

Similar Documents

Publication Publication Date Title
ATE4956T1 (de) Nitroglycerin enthaltendes praeparat und moeglicherweise andere medikamente und deren herstellung.
KR880009639A (ko) 서방성 매트릭스 제형
IT1230742B (it) Composizione per aerosol comprendente nitroglicerina come ingrediente attivo.
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
ES8800037A1 (es) Procedimiento para solubilizar drogas en propulsores de aerosol a base de clorofluorcarburos
IL53594A (en) Biological cells comprising pharmaceutically active substances and additives controlling their release from the cells,their preparation and pharmaceutical compositions containing them
ES488168A0 (es) Proceso para la preparacion de tabletas farmaceuticas o medicinales de administracion oral, con liberacion retardada delagente activo, en tabletas en las que la cantidad de libera-cion del agente activo es predeterminada.
KR900007837A (ko) 퀴누클리딘, 약제로서 이의 용도 및 이의 제조방법
ES2038643T3 (es) Procedimiento para la obtencion de una composicion farmaceutica topica.
ATE84032T1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
EP0382066A3 (de) Verwendung von Dihydroliponsäure als Analgetikum, Antiphlogistikum und/oder Zytoprotektivum
ES8201419A1 (es) Un metodo para preparar una solucion acuosa de nitrogliceri-na
KR860000865A (ko) 약제 제형의 제조방법
JPS542316A (en) Solid pharmaceutical composition containing nifedipene
DE69119810D1 (de) Pyrogensorbentmittel
IE781032L (en) Pharmaceutical compositions
ES2027773T3 (es) Dispositivo auto-adhesivo para administracion de un principio activo por via percutanea.
IL61207A0 (en) Cytostatically active pharmaceutical compositions comprising isocyanuric acid derivatives, certain such novel derivatives and their preparation
UA40636C2 (uk) Фармацевтична композиція для одержання стабільного порошку, яка містить як активний компонент асоціацію ацетилсаліцилової кислоти та метоклопраміду, фармацевтичний препарат у формі порошку та спосіб одержання цього препарату
AU566228B2 (en) Compressed hydroxybutryic acid polymer retarded release vehicle
ES433860A1 (es) Procedimiento de preparacion de derivados del acido ciclo- pentano-carboxilico.
GB2021409A (en) Pharmaceutical composition
JPS5350141A (en) Stabilization of prostaglandin and prostaglandin analogues
GB999739A (en) Analgesic compositions
BE881834A (fr) Medicaments et preparations pharmaceutiques a activite cytostatique

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee